XOMA Royalty Corp. Files 8-K on Asset Acquisition/Disposition
Ticker: XOMAP · Form: 8-K · Filed: Dec 5, 2025 · CIK: 791908
| Field | Detail |
|---|---|
| Company | Xoma Royalty Corp (XOMAP) |
| Form Type | 8-K |
| Filed Date | Dec 5, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.0075, $0.05, $2.035 |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, disposition, assets
TL;DR
XOMA Royalty Corp. just filed an 8-K for asset acquisition/disposition. Big moves happening.
AI Summary
On December 5, 2025, XOMA Royalty Corp. filed an 8-K report detailing the completion of an acquisition or disposition of assets. The filing also includes other events and financial statements and exhibits. XOMA Royalty Corp. is incorporated in Nevada and its fiscal year ends on December 31.
Why It Matters
This filing indicates a significant corporate action by XOMA Royalty Corp., potentially impacting its asset base and future financial performance.
Risk Assessment
Risk Level: medium — Acquisitions and dispositions of assets can introduce significant financial and operational risks.
Key Players & Entities
- XOMA Royalty Corp. (company) — Filer of the 8-K report
- December 5, 2025 (date) — Date of the earliest event reported
- Nevada (location) — State of incorporation
FAQ
What specific assets were acquired or disposed of by XOMA Royalty Corp.?
The filing does not specify the exact assets involved in the acquisition or disposition.
What was the financial value of the asset transaction?
The filing does not disclose the dollar amount of the acquisition or disposition.
When did the asset acquisition or disposition officially close?
The report indicates December 5, 2025, as the date of the earliest event reported, likely the closing date.
Are there any other significant events reported in this 8-K besides the asset transaction?
Yes, the filing notes 'Other Events' and 'Financial Statements and Exhibits' in addition to the completion of an acquisition or disposition of assets.
What is XOMA Royalty Corp.'s primary business sector?
XOMA Royalty Corp. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
Filing Stats: 1,682 words · 7 min read · ~6 pages · Grade level 11.9 · Accepted 2025-12-05 09:15:30
Key Financial Figures
- $0.0075 — ange on which registered Common Stock, $0.0075 par value XOMA The Nasdaq Global Ma
- $0.05 — ve Perpetual Preferred Stock, par value $0.05 per share XOMAP The Nasdaq Global M
- $2.035 — ere entitled to receive a cash price of $2.035 per share (the " Consideration "). In a
Filing Documents
- d20776d8k.htm (8-K) — 40KB
- d20776dex21.htm (EX-2.1) — 625KB
- d20776dex991.htm (EX-99.1) — 14KB
- g20776g1204234658833.jpg (GRAPHIC) — 6KB
- 0001193125-25-308794.txt ( ) — 971KB
- xoma-20251205.xsd (EX-101.SCH) — 4KB
- xoma-20251205_def.xml (EX-101.DEF) — 14KB
- xoma-20251205_lab.xml (EX-101.LAB) — 24KB
- xoma-20251205_pre.xml (EX-101.PRE) — 15KB
- d20776d8k_htm.xml (XML) — 8KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (a) Financial Statements of Business Acquired. The financial statements of Mural and related notes as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements of Mural as of September 30, 2025 and 2024 and for the periods then ended and related notes will be included in an exhibit that will be filed in an amendment to this Current Report on Form 8-K within the period specified in Item 9.01(a)(3) of Form 8-K. (b) Pro Forma Financial Information. The unaudited pro forma condensed combined financial information of XOMA and Mural as of and for the nine months ended September 30, 2025 and the year ended December 31, 2024 and the related notes will be included in an exhibit that will be filed in an amendment to this Current Report on Form 8-K within the period specified in Item 9.01(a)(3) of Form 8-K. (d)Exhibits. Exhibit No. Description 2.1 Transaction Agreement, by and among XOMA Royalty Corporation, XRA 5 Corp. and Mural Oncology plc, dated August 20, 2025. * 99.1 Press Release issued by XOMA Royalty Corporation on December 5, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Certain exhibits, annexes and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted exhibits, annexes and schedules upon request by the SEC; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any annexes or schedules so furnished.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. XOMA ROYALTY CORPORATION Date: December 5, 2025 By: /s/ Owen Hughes Name: Owen Hughes Title: Chief Executive Officer